Clinical Trial Update: Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating azacitidine in combination with rituximab, vincristine, and cyclophosphamide for refractory lymphoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Shams Shakil | Conditions: Lymphoma, Hodgkin Disease | Phase 1 | Status: COMPLETED